Monocytes in Hodgkin's disease
- PMID: 2472322
Monocytes in Hodgkin's disease
Abstract
It should be stated, there exist many abnormalities of monocytes function in HD patients, while examined in vitro. Their biological significance in vivo remains to be elucidated. The disturbances of monocyte-macrophage system certainly influence the immunoregulation mechanism, especially T-cell-macrophage cooperation and this way augment the immune deficite observed in patients with HD, increase their susceptibility to infections and may be an additional factor favoring tumour dissemination, particularly in the advanced stages of the disease.
Similar articles
-
[The monocyte-macrophage system in Hodgkin's disease].Medicina (B Aires). 1989;49(2):101-4. Medicina (B Aires). 1989. PMID: 2640476 Spanish.
-
Phenotypic attributes of the malignant cell population in Hodgkin's disease indicate a monocyte/macrophage origin.Cancer Surv. 1985;4(2):421-38. Cancer Surv. 1985. PMID: 3842320
-
Partial review of immunotherapeutic pharmacology in stem cell transplantation.In Vivo. 2000 Jan-Feb;14(1):221-36. In Vivo. 2000. PMID: 10757081 Clinical Trial.
-
Suppression of monocyte dependent lymphocyte stimulation by sera from patients with Hodgkin's disease.J Clin Lab Immunol. 1982 Jan;7(1):51-4. J Clin Lab Immunol. 1982. PMID: 6461767
-
Depressed T cell proliferative responses in Hodgkin's disease: role of monocyte-mediated suppression via prostaglandins and hydrogen peroxide.J Immunol. 1982 Oct;129(4):1770-4. J Immunol. 1982. PMID: 6980949
Publication types
MeSH terms
LinkOut - more resources
Medical